No Picture
News

Ionis announces positive interim data from partner Roche’s Phase 3 IMAgINATION study in IgA nephropathy (IgAN)

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and partner Roche today announced positive prespecified interim results from the ongoing Phase 3 IMAgINATION study evaluating investigational sefaxersen in adults with primary IgA nephropathy (IgAN). The study […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

100 Consecutive Sports Medicine Cases, Zero Documented Wound Complications With Brijjit® Tissue Bridges

100 consecutive orthopedic cases demonstrate the use of force-modulating tissue bridges across ACL, knee, shoulder, elbow and ankle procedures. SAN DIEGO, Sept. 22, 2026 /PRNewswire/ — BRIJ Medical today announced the publication of a new […]

No Picture
San Diego Biotech Jobs

Biosimilar Account Specialist

Join Amplity, the full-service go-to partner of biopharma companies that delivers flexible + specialized medical + commercial services. No… Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks
News

Circular Genomics and Altoida Announce Collaboration to Advance First-of-Kind Multimodal Precision Medicine for Alzheimer’s Disease

Companies aim to combine blood-based circRNA biomarkers of disease biology and pathology with objective digital measures of cognition and function, to accelerate Alzheimer’s drug development today and create a scalable frontline care tomorrow. SAN DIEGO […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Anaptys Announces Second Quarter and Transitional Fiscal Year 2026 Financial Results and Provides Business Update

SAN DIEGO, Sept. 21, 2026 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, today reported financial […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Iambic Launches Enchant v3 – Molecular Superintelligence Designed to Advance End-to-End Drug Discovery & Development

SAN DIEGO–(BUSINESS WIRE)–Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today unveiled Enchant v3, the next generation of its multimodal transformer model built to advance end-to-end drug discovery […]

No Picture
San Diego Biotech Jobs

Staff Scientist – San Diego, CA 92122

Job details $118,200 – $177,200 a year Encouraged to apply   Pulled from the full job description Retirement plan Paid time off Vision insurance Dental insurance   What if… Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
San Diego Biotech Jobs

Research Technician I / II – San Diego, CA 92121

Job details   Pulled from the full job description Health insurance Retirement plan Paid time off Vision insurance Dental insurance Life insurance Disability insurance   About San Diego BioMed: San… Click here to view original […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Arcturus Therapeutics to Present Ornithine Transcarbamylase (OTC) Deficiency Phase 2 Clinical Data and Provide Update on mRNA Liver Therapeutics Platform

SAN DIEGO–(BUSINESS WIRE)—- $ARCT #65Roses–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that it will host […]

No Picture
News

L?kahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent

RUTHERFORD, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)–L?kahi Therapeutics™ renews its University of Alabama collaboration, advancing real-world asset evaluation and developing key future biopharma talent. Click here to view original post Click Here to Publish/Feature Your […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033

SAN DIEGO, Sept. 17, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme” or the “Company”), today announced the pricing of $1.3 billion aggregate principal amount of 1.50% convertible senior notes due 2033 (the “Convertible […]

No Picture
San Diego Biotech Jobs

QC Support Analyst 3

Would you like to join an international team working to improve the future of healthcare?… Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks